Stay updated on Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.

Latest updates to the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page
- CheckyesterdayChange DetectedAdded a new revision label 'Revision: v3.3.3' to the record history and removed the 'HHS Vulnerability Disclosure' item along with 'Revision: v3.3.2' from the page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision history shows the addition of v3.3.2 and the deletion of v3.2.0 for the NCT03529253 record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe notice about government funding and potential delays in updates at the top of the page was removed, reducing visible context about data currency. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check52 days agoChange DetectedRecord History shows updates to Study Status, Recruitment Status, and changes to Arms/Interventions and Eligibility across versions. These updates reflect progress and adjustments to the trial details.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference13%

- Check88 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.